Prof. Dr. Falk Nimmerjahn



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Tissue niche occupancy determines the contribution of fetal- versus bone-marrow-derived macrophages to IgG effector functions (2024) Wöhner M, Brechtelsbauer S, Friedrich N, Vorsatz C, Bulang J, Liang C, Schorr L, et al. Journal article Functional Fc receptors are crucial in antibody-mediated protection against cytomegalovirus (2024) Bootz A, Reuter N, Nimmerjahn F, Britt WJ, Mach M, Winkler TH Journal article Immunomodulatory and anti-inflammatory properties of immunoglobulin G antibodies (2024) Hematianlarki M, Nimmerjahn F Journal article, Review article Sialic acids on T cells are crucial for their maintenance and survival (2024) Schmidt M, Linder A, Korn M, Schellenberg N, Meyer SJ, Nimmerjahn F, Werner A, et al. Journal article IgG sialylation occurs in B cells pre antibody secretion (2024) Werner A, Hanić M, Zaitseva OO, Lauc G, Lux A, Nitschke L, Nimmerjahn F Journal article Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer (2024) Heger L, Heidkamp GF, Amon L, Nimmerjahn F, Bäuerle T, Maier A, Erber R, et al. Journal article Analyzing Fcγ-Receptor Interactions on Monocytes with the Proximity Ligation Assay (PLA) (2024) Kara S, Nimmerjahn F Journal article Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM study (2023) Schifferli A, Rüfer A, Rovo A, Nimmerjahn F, Cantoni N, Holbro A, Favre G, et al. Journal article Mixed IgG Fc immune complexes exhibit blended binding profiles and refine FcR affinity estimates (2023) Tan ZC, Lux A, Biburger M, Varghese P, Lees S, Nimmerjahn F, Meyer AS Journal article Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment (2023) Haake M, Haack B, Schäfer T, Harter PN, Mattavelli G, Eiring P, Vashist N, et al. Journal article